Skip to content

Clinical trials

Phase 4 Coronary Artery Disease trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 4 Country / region: Czechia Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20091
20111
20121
20131

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices1
Baim Institute for Clinical Research1
General University Hospital, Prague1
Gilead Sciences1
Onze Lieve Vrouw Hospital1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease6
Myocardial Ischemia2
Acute Coronary Syndrome1
Angina Pectoris1
Coronary Disease1
Coronary Restenosis1
Coronary Stenosis1
Diabetes Mellitus, Type 21
Hypercholesterolemia1
Myocardial Infarction1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.